Back
AnaptysBio, Inc. ANAB · Insights
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeut... Price47.97
Market Cap1.43 B
Float27.92 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro